Skrabek Pamela, Turner Donna, Seftel Matthew
Department of Medical Oncology and Haematology, CancerCare Manitoba, Canada; Department of Community Health Sciences, University of Manitoba, Canada.
Transfus Apher Sci. 2013 Oct;49(2):133-8. doi: 10.1016/j.transci.2013.07.014. Epub 2013 Aug 16.
Non-Hodgkin Lymphoma (NHL) occurs worldwide although there is notable geographical variation in incidence and subtype distribution. These differences are due to a combination of demographic, environmental and other unidentified factors. A dramatic increase in NHL incidence was seen starting around 1970, with subsequent stabilization 10 years ago. Despite this plateau, the number of new cases in many countries will increase significantly in coming years due primarily to aging populations. In the majority of cases, strong risk factors are not identifiable. There is significant epidemiological heterogeneity between NHL subtypes, yet cancer registries have tended to consider NHL as a single entity. This is one of several epidemiological obstacles discussed.
非霍奇金淋巴瘤(NHL)在全球范围内均有发生,尽管其发病率和亚型分布存在显著的地域差异。这些差异是由人口统计学、环境及其他不明因素共同导致的。自1970年左右开始,NHL发病率急剧上升,随后在10年前趋于稳定。尽管处于平稳状态,但由于人口老龄化,未来几年许多国家的新发病例数仍将显著增加。在大多数情况下,无法确定强烈的风险因素。NHL各亚型之间存在显著的流行病学异质性,但癌症登记处往往将NHL视为一个单一实体。这是所讨论的几个流行病学障碍之一。